Kueder-Pajares T, Descalzo M A, García-Doval I, Ríos-Buceta L, Moreno-Ramírez D
Servicio de Dermatología, Hospital de Fuenlabrada, Fuenlabrada, Madrid, España.
Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España.
Actas Dermosifiliogr (Engl Ed). 2018 Nov;109(9):807-812. doi: 10.1016/j.ad.2018.06.004. Epub 2018 Aug 6.
A series of quality indicators for melanoma and nonmelanoma skin cancer were recently approved within a project promoted by the Healthy Skin Foundation of the Spanish AEDV. The aim of this study was to evaluate adherence to these indicators.
In November 2016, an anonymous questionnaire consisting of 32 items was sent to the heads of Spanish dermatology and venereology departments listed in the AEDV's database. The questions referred to the above-mentioned quality of care indicators.
The questionnaire was completed by 104 of the 150 people contacted (response rate, 69.3%). The lowest response rate for any given question was 56% (84 respondents). Over 85% of respondents answered 29 questions or more (91%). The most widely used indicators were those related to the use of computed tomography or magnetic resonance imaging for squamous cell carcinoma (98%), followed by the availability of a standardized melanoma pathology report (90%). The least widely used indicators were related to availability of electrochemotherapy (25%) and other invasive therapies for locoregionally advanced melanoma (20%).
Adherence to quality of cancer care criteria at the different hospitals evaluated varied. Our findings could be useful for identifying areas for improvement at different hospitals. Future studies should focus on measuring both process and outcome indicators.
西班牙皮肤性病学会健康皮肤基金会推动的一个项目最近批准了一系列黑色素瘤和非黑色素瘤皮肤癌的质量指标。本研究旨在评估对这些指标的依从性。
2016年11月，一份包含32个项目的匿名问卷被发送给西班牙皮肤性病学会数据库中列出的皮肤科和性病科负责人。这些问题涉及上述护理质量指标。
150名被联系者中有104人完成了问卷（回复率为69.3%）。任何一个给定问题的最低回复率为56%（84名受访者）。超过85%的受访者回答了29个或更多问题（91%）。使用最广泛的指标是与鳞状细胞癌使用计算机断层扫描或磁共振成像相关的指标（98%），其次是标准化黑色素瘤病理报告的可用性（90%）。使用最不广泛的指标与电化学疗法的可用性（25%）和局部晚期黑色素瘤的其他侵入性疗法（20%）有关。
在所评估的不同医院中，对癌症护理质量标准的依从性各不相同。我们的研究结果可能有助于确定不同医院需要改进的领域。未来的研究应侧重于衡量过程指标和结果指标。
